A similar phenomenon existed in ovarian tumor-initiated cells (TICs) that they had higher expression of TFR1 and lower level of ferroportin-1 (FPN) and exhibited increased sensitivity to Erastin [102], hinting that combo of FITs and FAM targeting strategy would be more effective in selective subtypes of ovarian cancer. The gene discussed is SLC40A1; the disease is ovarian cancer.